C

Concord Drugs Ltd
BSE:538965

Watchlist Manager
Concord Drugs Ltd
BSE:538965
Watchlist
Price: 83.06 INR -4.69% Market Closed
Market Cap: 830.6m INR

Intrinsic Value

538965 price has not been updated for more than 3 years. This may indicate that the stock has been delisted.
538965 doesn't have a meaningful market cap.

The intrinsic value of one CONCORD stock under the Base Case scenario is hidden INR. Compared to the current market price of 83.06 INR, Concord Drugs Ltd is hidden .

The Intrinsic Value is calculated as the average of DCF and Relative values:

CONCORD Intrinsic Value
HIDDEN
Show
Worst Case
Base Case
Best Case

Valuation History
Concord Drugs Ltd

Intrinsic Value History
Dive into the past to invest in the future

CONCORD looks overvalued. Yet it might still be cheap by its own standards. Some stocks live permanently above intrinsic value; Historical Valuation reveals whether CONCORD usually does or if today's premium is unusual.

Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Show Historical Valuation
What is Valuation History?
Ask AI Assistant
What other research platforms think about CONCORD?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is CONCORD valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for Concord Drugs Ltd.

Explain Valuation
Compare CONCORD to

Fundamental Analysis

Company Overview
Loading...
Economic Moat
Loading...
Contacts
Loading...
How do you feel about CONCORD?
Bearish
Neutral
Bullish
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Concord Drugs Ltd

Current Assets 407.6m
Cash & Short-Term Investments 3.5m
Receivables 136m
Other Current Assets 268.1m
Non-Current Assets 243.8m
Long-Term Investments 14.4m
PP&E 135.7m
Other Non-Current Assets 93.7m
Current Liabilities 261.8m
Accounts Payable 76.2m
Other Current Liabilities 185.6m
Non-Current Liabilities 48.5m
Long-Term Debt 13.2m
Other Non-Current Liabilities 35.2m
Efficiency

Free Cash Flow Analysis
Concord Drugs Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Concord Drugs Ltd

Revenue
471.6m INR
Cost of Revenue
-376.3m INR
Gross Profit
95.3m INR
Operating Expenses
-66.7m INR
Operating Income
28.6m INR
Other Expenses
-24.3m INR
Net Income
4.3m INR
Fundamental Scores

CONCORD Profitability Score
Profitability Due Diligence

Concord Drugs Ltd's profitability score is hidden . The higher the profitability score, the more profitable the company is.

Sustainable 3Y Average Gross Margin
Healthy Gross Margin
Operating Margin is Increasing
Declining Net Margin
hidden
Profitability
Score

Concord Drugs Ltd's profitability score is hidden . The higher the profitability score, the more profitable the company is.

CONCORD Solvency Score
Solvency Due Diligence

Concord Drugs Ltd's solvency score is hidden . The higher the solvency score, the more solvent the company is.

Low D/E
Long-Term Solvency
Short-Term Solvency
Average Altman Z-Score
hidden
Solvency
Score

Concord Drugs Ltd's solvency score is hidden . The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

CONCORD Price Targets Summary
Concord Drugs Ltd

There are no price targets for CONCORD.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
View Analyst Estimates
View Analyst Estimates

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for CONCORD is hidden .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
HIDDEN
Show
Dividend Yield
Lowest
Average
Highest
Buyback Yield
HIDDEN
Debt Paydown Yield
HIDDEN

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y
What is the Intrinsic Value of one CONCORD stock?

The intrinsic value of one CONCORD stock under the Base Case scenario is hidden INR.

Is CONCORD stock undervalued or overvalued?

Compared to the current market price of 83.06 INR, Concord Drugs Ltd is hidden .

Back to Top